Can Cyclobenzaprine (Flexeril) and Meloxicam Be Taken Together?
Yes, cyclobenzaprine and meloxicam can be taken together safely, and this combination is actually supported by clinical evidence showing enhanced efficacy for acute musculoskeletal pain compared to either agent alone.
Evidence Supporting Combination Therapy
The combination of a muscle relaxant (cyclobenzaprine) with an NSAID (meloxicam or similar agents) is well-established in clinical practice:
A randomized trial directly demonstrated that cyclobenzaprine combined with naproxen (another NSAID like meloxicam) provided superior relief of muscle spasm and tenderness compared to naproxen alone in patients with acute low back pain 1.
The combination therapy resulted in less objective muscle spasm, reduced tenderness, and greater range of motion in the lumbosacral spine (P < 0.05) 1.
Guidelines for acute low back pain support the use of skeletal muscle relaxants, which are moderately superior to placebo for short-term pain relief, and these are commonly combined with NSAIDs in clinical practice 2.
Safety Considerations
No Direct Drug-Drug Interaction
The FDA labeling for cyclobenzaprine does not list NSAIDs like meloxicam as contraindicated or requiring special precautions 3. The primary drug interactions of concern with cyclobenzaprine involve:
- MAO inhibitors (contraindicated) 3
- Serotonergic drugs (SSRIs, SNRIs, TCAs, tramadol, bupropion) - risk of serotonin syndrome 3
- CNS depressants (alcohol, barbiturates) - enhanced sedative effects 3
Additive Side Effects to Monitor
While safe to combine, be aware of additive side effects:
Cyclobenzaprine's most common adverse effects are drowsiness, fatigue, dizziness, and sedation 1, 4. The combination therapy in clinical trials showed more side effects primarily due to drowsiness from cyclobenzaprine 1.
Meloxicam carries standard NSAID risks including GI bleeding, cardiovascular complications, and renal impairment 5. These risks are independent of cyclobenzaprine use.
Practical Prescribing Approach
Dosing Strategy
Cyclobenzaprine: 5 mg three times daily is effective and better tolerated than higher doses 4. The lower dose minimizes sedation while maintaining efficacy.
Meloxicam: Standard dosing is 7.5-15 mg once daily. Consider GI prophylaxis with a PPI in patients with risk factors for GI bleeding 5.
Duration of Therapy
Limit cyclobenzaprine to short-term use (2 weeks or less) - all efficacy trials for acute musculoskeletal pain used treatment durations of 2 weeks or less 2.
Meloxicam can be continued longer if needed for ongoing inflammation, following standard NSAID precautions 5.
Patient Counseling Points
Warn about drowsiness and sedation - advise against driving or operating machinery until response is known 1, 4.
Take cyclobenzaprine at bedtime if sedation is problematic - this can turn the side effect into a therapeutic benefit for sleep disturbance 6.
Monitor for NSAID-related complications including dyspepsia, blood pressure changes, and signs of GI bleeding 5.
Common Pitfalls to Avoid
Do not avoid this combination due to unfounded interaction concerns - there is no pharmacokinetic or pharmacodynamic interaction between these agents that would preclude their use together.
Do not use cyclobenzaprine in elderly patients - plasma levels increase by 40% and half-life by 56% in elderly patients, making it not recommended in this population 3.
Do not use cyclobenzaprine in patients with hepatic impairment - plasma levels are doubled even in mild hepatic impairment 3.
Screen for contraindications to each drug individually - particularly MAO inhibitor use for cyclobenzaprine and cardiovascular/renal disease for meloxicam 5, 3.